Thursday, July 9, 2026

pharma · Osteoarthritis, Knee · Eosinophilic esophagitis · EPRX

EUPRAXIA PHARMACEUTICALS

EUPRAXIA PHARMACEUTICALS trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Victoria, CA HQ
2012 Founded
52 Employees
Public company Type
EPRX · NYSE Ticker
Company details
Status
Public
HQ
Victoria, CA
Founded
2012
Employees
52
Programs
4
Drugs
1
Patents
3
Intelligence · Clinical Trials

EUPRAXIA PHARMACEUTICALS clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to EUPRAXIA PHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.

EUPRAXIA PHARMACEUTICALS trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for EUPRAXIA PHARMACEUTICALS.

  1. TETRACOSACTIDE , EP-104GI — Phase 2

    Clinical update
  2. EP-104GI — Phase 2

    Clinical update
  3. EP-104IAR 25 mg — Phase 2

    Clinical update
  4. EP-104IAR — Phase 1

    Clinical update

Trial registry

4 studies